Signal

$ABBV — Biopharmaceutical company focused on immunology and oncology.

Adjusted EPS beat expectations, driven by strong immunology sales.

ABBV

$253.35

+4.20%

JNJ

$254.66

+3.99%

PFE

$24.29

+2.62%

What changed

$ABBV — Biopharmaceutical company focused on immunology and oncology. Adjusted EPS beat expectations, driven by strong immunology sales. - REV +12.3% to $13.2B - EPS +7.7% to $2.65 Related: $JNJ $PFE $MRK $LLY $BMY $TMO

Why it matters

Adjusted EPS beat expectations, driven by strong immunology sales. - REV +12.3% to $13.2B

Sources

pipeline